Ark Therapeutics Group Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 58

Employees

  • Latest Deal Type
  • IPO

  • Latest Deal Amount
  • $103M

Ark Therapeutics Group General Information

Description

Operator of a specialty healthcare company intended to discover, develop and commercialize novel viral-based gene therapies and targeted vascular medicines. The company offers specialized adenoviral vector manufacturing and targeted gene therapy delivery platforms, enabling healthcare providers and biopharmaceutical developers to address unmet medical needs in vascular diseases, oncology, and severe tissue-specific conditions through targeted localized treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 20-22 Wenlock Road
  • London N1 7GU
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 20-22 Wenlock Road
  • London N1 7GU
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ark Therapeutics Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 08-Mar-2004 $103M Completed Generating Revenue
3. Grant Completed Startup
2. Early Stage VC 01-Sep-2001 $20.9M $21M Completed Startup
1. Angel (individual) 01-Jan-2001 $150K $150K Completed Startup
To view Ark Therapeutics Group’s complete valuation and funding history, request access »

Ark Therapeutics Group Patents

Ark Therapeutics Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140121160-A1 Use of vegf in the treatment of retarded fetal growth in pregnancy Inactive 29-Oct-2012
GB-201116880-D0 Vector Inactive 30-Sep-2011
GB-201111218-D0 Sequence Inactive 01-Jul-2011
GB-201111219-D0 Sequence Inactive 01-Jul-2011
CA-2824689-A1 Combination therapy for cancer Active 18-Jan-2011 A61K31/7088
To view Ark Therapeutics Group’s complete patent history, request access »

Ark Therapeutics Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ark Therapeutics Group Acquisitions (2)

Ark Therapeutics Group’s most recent deal was a Merger/Acquisition with Premier Vet Alliance for . The deal was made on 05-Feb-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Premier Vet Alliance 05-Feb-2015 Merger/Acquisition Other Services (B2C Non-Financial)
Lymphatix 08-Jan-2008 Merger/Acquisition Drug Discovery
To view Ark Therapeutics Group’s complete acquisitions history, request access »

Ark Therapeutics Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Premier Vet Alliance Bristol, United Kingdom 2001

Ark Therapeutics Group FAQs

  • When was Ark Therapeutics Group founded?

    Ark Therapeutics Group was founded in 2001.

  • Where is Ark Therapeutics Group headquartered?

    Ark Therapeutics Group is headquartered in London, United Kingdom.

  • What is the size of Ark Therapeutics Group?

    Ark Therapeutics Group has 58 total employees.

  • What industry is Ark Therapeutics Group in?

    Ark Therapeutics Group’s primary industry is Drug Discovery.

  • Is Ark Therapeutics Group a private or public company?

    Ark Therapeutics Group is a Private company.

  • What is the current valuation of Ark Therapeutics Group?

    The current valuation of Ark Therapeutics Group is .

  • What is Ark Therapeutics Group’s current revenue?

    The current revenue for Ark Therapeutics Group is .

  • How much funding has Ark Therapeutics Group raised over time?

    Ark Therapeutics Group has raised $124M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process